Episode 10: Cytokines Levels and Response to Ranibizumab in DME with Dr. Rajeev Muni

Related

• 

  Do scheduling issues impact commonly needed testing for patients with moderate diabetic retinopathy with macular edema?

  Leonard H. Ginsburg, MD

  On Demand Cases, Courses, and Papers

  2019

• 

  Expert Panel: Faricimab and Aflibercept 8 mg in Diabetic Retinopathy

  Judy E. Kim, MD, FASRS

  Chirag D. Jhaveri, MD, FASRS

  Michael S. Ip, MD

  Arshad M. Khanani, MD, MA, FASRS

  Jordana G Fein, MD, MS

  Dennis M. Marcus, MD

  Diana V Do, MD, FASRS

  Annual Meeting Talks

  2024

• 

  Trends in the treatment of proliferative diabetic retinopathy before and after the Diabetic Retinopathy Clinical Research Network Protocol S study

  John W Hinkle, MD

  Updates from the Field

  2020